Synthesis, Characterization, Cytotoxic Activity, and Metabolic Studies of Ruthenium(II) Polypyridyl Complexes Containing Flavonoid Ligands
- 19 March 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 59 (7), 4424-4434
- https://doi.org/10.1021/acs.inorgchem.9b03562
Abstract
Four novel monocationic Ru(II) polypyridyl complexes were synthesized with the general formula [Ru(DIP)2flv]X, where DIP is 4,7-diphenyl-1,10-phenanthroline, flv stands for the flavonoid ligand (5-hydroxyflavone in [Ru(DIP)2(5-OHF)](PF6), genistein in [Ru(DIP)2(gen)](PF6), chrysin in [Ru(DIP)2(chr)](OTf), and morin in [Ru(DIP)2(mor)](OTf)), and X is the counterion, PF6−, and OTf ̅ (triflate, CF3SO3̅), respectively. Following the chemical characterization of the complexes by 1H and 13C NMR, mass spectrometry, and elemental analysis, their cytotoxicity was tested against several cancer cell lines. The most promising complex, [Ru(DIP)2(gen)](PF6), was further investigated for its biological activity. Metabolic studies revealed that this complex severely impaired mitochondrial respiration and glycolysis processes, contrary to its precursor, Ru(DIP)2Cl2, which showed a prominent effect only on the mitochondrial respiration. In addition, its preferential accumulation in MDA-MB-435S cells (a human melanoma cell line previously described as mammary gland/breast; derived from metastatic site: pleural effusion), which are used for the study of metastasis, explained the better activity in this cell line compared to MCF-7 (human, ductal carcinoma).Funding Information
- Agence Nationale de la Recherche (ANR-10-IDEX-0001-02 PSL)
- H2020 European Research Council (GA 681679)
- Universitatea de Medicina si Farmacie \"Carol Davila\" Bucuresti (23PFE/17.10.2018)
- Region ?le-de-France (12015908)
This publication has 65 references indexed in Scilit:
- Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cellsJournal of Inorganic Biochemistry, 2013
- Structure–Activity Relationships of Targeted RuII(η6-p-Cymene) Anticancer Complexes with Flavonol-Derived LigandsJournal of Medicinal Chemistry, 2012
- Flavonoids: A versatile source of anticancer drugsPharmacognosy Reviews, 2011
- Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen speciesMolecular Nutrition & Food Research, 2010
- Mechanism of Cellular Uptake of a Ruthenium Polypyridyl ComplexBiochemistry, 2008
- Methods to Explore Cellular Uptake of Ruthenium ComplexesJournal of the American Chemical Society, 2006
- MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma researchBreast Cancer Research and Treatment, 2006
- A New Family of Mono- and Dicarboxylic Ruthenium Complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): Synthesis, Solution Behavior, and X-ray Molecular Structure of trans-[Ru(DIP)2(MeOH)2][OTf]2Inorganic Chemistry, 2006
- Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosisOncogene, 2002
- The aluminium(III) complexes of hydroxyflavones in absolute methanol. Part II. Ligands containing more than one chelating siteJournal of the Chemical Society C: Organic, 1970